Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Corvus Pharmaceuticals In...

    NASDAQ: CRVS · Real-Time Price · USD
    4.07
    0.16 (4.09%)
    At close: Jun 06, 2025, 1:43 PM

    Corvus Pharmaceuticals Statistics

    Share Statistics

    Corvus Pharmaceuticals has 77.11M shares outstanding. The number of shares has increased by 8.93% in one year.

    Shares Outstanding

    n/a
    		 77.11M

    Shares Change (YoY)

    n/a
    		 8.93%

    Shares Change (QoQ)

    n/a
    		 6.04%

    Owned by Institutions (%)

    n/a
    		 56.48%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 800

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 7.23M, so 9.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 7.23M

    Short % of Shares Out

    n/a
    		 9.38%

    Short % of Float

    n/a
    		 11.76%

    Short Ratio (days to cover)

    n/a
    		 3.59

    Valuation Ratios

    The PE ratio is -5.24 and the forward PE ratio is -6.09. Corvus Pharmaceuticals's PEG ratio is -0.06.

    PE Ratio

    n/a
    		 -5.24

    Forward PE

    n/a
    		 -6.09

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.8

    PB Ratio

    n/a
    		 10.02

    P/FCF Ratio

    n/a
    		 -12.83

    PEG Ratio

    n/a
    		 -0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Corvus Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 1.54

    Quick Ratio

    n/a
    		 1.54

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.04

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -15.1

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,009,451.61

    Employee Count

    n/a
    		 31

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 86.67% in the last 52 weeks. The beta is 0.57, so Corvus Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.57

    52-Week Price Change

    n/a
    		 86.67%

    50-Day Moving Average

    n/a
    		 3.47

    200-Day Moving Average

    n/a
    		 5.31

    Relative Strength Index (RSI)

    n/a
    		 55.05

    Average Volume (20 Days)

    n/a
    		 1,012,788

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -27.55M

    Net Income

    n/a
    		 -62.29M

    EBITDA

    n/a
    		 -27.55M

    EBIT

    n/a
    		 -60.47M

    Earnings Per Share (EPS)

    n/a
    		 -1.02
    Full Income Statement

    Balance Sheet

    The company has 8.74M in cash and 1.12M in debt, giving a net cash position of 7.62M.

    Cash & Cash Equivalents

    n/a
    		 8.74M

    Total Debt

    n/a
    		 1.12M

    Net Cash

    n/a
    		 7.62M

    Retained Earnings

    n/a
    		 -397.01M

    Total Assets

    n/a
    		 59.44M

    Working Capital

    n/a
    		 36.21M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -25.42M and capital expenditures 0, giving a free cash flow of -25.42M.

    Operating Cash Flow

    n/a
    		 -25.42M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -25.42M

    FCF Per Share

    n/a
    		 -0.42
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CRVS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CRVS is $14, which is 257.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $14

    Price Target Difference

    n/a
    		 257.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.3

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist